In October 1972, the First International Workshop for Therapy of Lung Cancer was held at Airlie House Conference Center outside Washington D.C. This conference, sponsored by the National Cancer Institute, drew together exchange of ideas among this multi-disciplinary international group was both productive and stimulating. At the concluding meeting, held on October 20, 1972, Dr. David T. Carr from the Mayo Clinic, USA, introduced the idea of forming an international organization to continue this fruitful exchange of ideas, and generally enthusiastic support for the concept was voiced by those present at the workshop.
An organizing committee was formed and Dr. David T. Carr accepted chairmanship of a committee to prepare a constitution and bylaws. Dr. Oleg S. Selawry, with the assistance of Drs. Lawrence Broder and George Higgins from the Washington V.A. Hospital, USA, and other members of the organization committee began the slow task of development. Questionnaires and applications were sent to a wide variety of individuals with interest in the problem of lung cancer throughout the world, as well as to those who had attended the Airlie meeting. By mid 1974, approximately 250 individuals had accepted membership in the Association and plans were made to have an organization meeting in conjunction with the XIth International Cancer Congress, sponsored by the UICC in Florence, Italy.
On the evening of October 26, 1974, in Florence, Italy, the first formal organizational meeting was held under the Chairmanship of Dr. Oleg S. Selawry. Bylaws of the Organization were discussed and adopted by unanimous vote. Dr. Clifton Mountain, M.D. Anderson Hospital, Houston, USA, presented the slate of officers and board of directors with results of the ballots which had been mailed out prior to the meeting. This slate of officers was unanimously elected.
A formal meeting of the Executive Committee was held on December 11, 1974, in Key Biscayne, Florida, and many subsequent informal meetings and discussions were held concerning development and goals for the Association. The Association was incorporated as a non-profit corporation. Membership certificates were designed, with the now familiar logo, prepared and mailed to all members. Periodic newsletters were prepared and disseminated to inform membership of organizational progress. Much of this work was done by Dr. Lawrence Broder, first Secretary of the Association.
Early in 1976, Dr. Selawry assumed a new position at the Miami Cancer Center and found it impossible to devote sufficient time to the developing organization and submitted his resignation in May of 1976. In Accordance with the Bylaws, the Vice-President, David T. Carr, assumed the office of President.
With this slow and somewhat tentative beginning, a solid foundation for the Organization had been established. Under the energetic leadership of Dr. Clifton Mountain, plans were made for the First World Congress on Lung Cancer, sponsored by IASLC. This highly successful conference was held in May of 1978, at Hilton Head, South Carolina, with large attendance by participants from throughout the world. Contributing greatly to the success of this meeting was Dr. Ronald Vincent, who served as Chairman of the conference. Now officers and directors were elected to serve during the period between 1978 and 1980. During this period, under Dr. George A. Higgins' leadership, there was a substantial increase in membership. Newsletters were regularly distributed and plans were made for the Second World Conference.
Under the chairmanship of Dr. Heine H. Hansen, the Second World Conference on Lung Cancer was held on June 9 to 13, 1980, in Copenhagen, Denmark, and Malmoe, Sweden. Over 1000 participants from throughout the world attended this highly successful conference. At the conclusion of the meeting, the officers and directors were elected for 1980-82.
Tokyo was chosen at the site of the Third World Conference on Lung Cancer, to he held May 17 to 20, 1982. Under the able guidance of Dr. Shichiro Ishikawa, Congress President, and the energetic assistance of Congress Vice President, Yoshihiro Hayata, the successful Third World Conference was attended by over 15000 participants representing most of the major nations of the world.
Decision was made to hold the International World Conference on Lung Cancer at three-year intervals instead of two years. Toronto was selected as the site for the Fourth International Conference on Lung Cancer with Dr. Ronald Feld serving as Secretary-General and Dr. Ronald Ginsberg as Chairman of the Program Committee.
The Fourth International Conference on Lung Cancer was held in Toronto in August of 1985, had an outstanding program of scientific content. One thousand participants registered for the conference, representing 33 nations. During this conference, some new actions were approved by the officers and the board of the Association. First, aggressive development of workshops and conferences to take place between world conferences; second, the format of a quarterly journal to be sponsored by the IASLC; and third, authorization was given to expand the business office of the association in Copenhagen, Denmark, in order to improve communication and develop the journal Lung Cancer. Finally, Interlaken, Switzerland, was chosen to host the 1988 conference, with Dr. Rudolf Joss as Secretary-General and Chairman of the Program Committee.
The Fifth World Conference on Lung Cancer, Interlaken 1988, was again very successful. Officers and directors were elected and Dr. Heine H. Hansen commenced his period of presidency. Melbourne, Australia, was chosen as the location of the 1991 World Conference, with David R. Ball as Chairman and Secretary-General.
The Sixth World Conference on Lung Cancer was attended by 1240 delegates from 47 countries and the first recipient of the IASLC Merit Award was to be found. It was decided that the award should be given to a person who had been an IASLC member for at least 10 years, had manifested himself/herself at an international level as a person engaged in the field of lung cancer, either preclinically or clinically, and had promoted the activities of the IASLC. It was unanimously agreed that the first recipient of the IASLC Merit Award should be Dr. Clifton Mountain.
Colorado Springs, USA, was chosen as the location for the 7th World Congress with Dr. Paul A. Bunn, Jr. as Secretary General. At the same time, Dr. Yoshihiro Hayata began his period as President, and Dr. Heine H. Hansen was elected Executive Director for the expanding IASLC Office located in Copenhagen. New activities were planned with a series of workshops, now also including Eastern Europe and South Africa. With the support from the industry, travelling and educational grants within the Organization were created for promising young investigators and colleagues from developing countries.
The Seventh World conference was a gigantic success scientifically, socially, and economically. Set in beautiful Colorado Springs, the meeting was attended by 1347 participants from 49 countries. The IASLC Merit Award was shared by Dr. Y. Shimosato and Dr. N. Bleehen. Seven more awards were given, including Developing Nations awards and Young Investigator awards. IASLC Recommendations on Tobacco Policy were established, and Dr. Paul A. Bunn, Jr., commenced his period of presidency. Dublin, Ireland, was chosen as the venue for the 8th World Conference with Dr. Desmond N. Carney as Secretary General.
After the Colorado meeting, several workshops were held on topics ranging from prevention to tumor biology. Also, the important and successful central European Lung Cancer Conferences continued with meetings in Prague, Czech Republic and Gdansk, Poland.
The 8th World Conference in Dublin took place in August 1997. Dr. Desmond N. Carney and his staff had put together an exciting and varied programme of science and entertainment. With the attendance of 2505 delegates from 63 countries, and a surplus which enabled IASLC to expand its activities during the next 3-year period, the Dublin meeting was a truly memorable event in the history if IASLC. The IASLC Merit Award was given to Dr. Heine H. Hansen, Copenhagen, in recognition of his longstanding contributions to the IASLC and the Mary J. Matthews Award was given to Dr. William D. Travis, Washington DC, for his excellence in lung cancer pathology.
Between the World Conferences in Dublin and Toyko, a total of 13 workshops, symposia, and other meetings were arranged under the auspices of IASLC, and 5 meetings were arranged under the Educational Programme in India, Thailand, China, Brazil and Jordan with speakers from the IASLC Facility.Under the chairmanship of Dr. Peter Goldstraw, UK, the IASLC Staging Committee launched in 1999 the cumbersome work of creating a new staging system for lung cancer based on a truly international data register.
The 9th World Conference was held in Toyko, Japan in September, 2000 with Dr. Y. Hayata as the Congress President. A total of 1130 abstracts were submitted to the Conference, which was attended by 2135 participants from 64 countries. Among the memorable events were the opening ceremony, attended by members of the Japanese imperial family, and the gigantic ball with traditional Japanese performers that made a superb conclusion to the conference. The IASLC Merit Award was given to Dr. Desmond N. Carne, Ireland, for his outstanding contribution to the IASLC; the Mary J. Matthews Award was given to Dr. Y. Shimosato, Japan, for his life long achievements in the field of pathology, and the Bristol-Myers Squibb Award was given to Daniel C. Ihde, U.S.A., for his dedication to lung cancer research and his support of IASLC and its aims. Dr. Harubumi Kato, Japan took over the Presidency and Dr. Franses Shepherd, Canada was chosen as the new President-Elect.
The Board decided on the Tokyo Declaration as an official IASLC document requesting governments worldwide to take actions against the alarming rate at which lung cancer is occurring in both men and women. The Tokyo Declaration is published in this Directory on page 11.
The first IASLC/CRFA Prevention Fellowship Award was presented in Tokyo to Dr. Jun Zhang, China and in the spring of 2001, two more Prevention Fellowship grants were awarded to Dr. Yunfei Wang, USA and Dr. Fred R. Hirsch, Denmark. Thanks to the energetic work of the President of CRFA, Carolyn Aldige, three more grants have been secured.
The IASLC Textbook of Lung Cancer, which was published in 1999, has now been translated into Chinese thanks to the efforts of Dr. Li Hou-wen, Shenyang, China.
In 2001, workshops and symposia have been arranged in Barcelona, Spain; in Prague, Czech Republic; in Reykjavik, Iceland, and in Chicago, USA. Under the IASLC Educational Programme, meetings and courses have been arranged in Dalian, China; in Istanbul, Turkey; in Bialystok. Poland and in Beijing, China.
The Vancouver Trade and Convention Centre was the venue for the 10th World Conference of Lung Cancer held in August 2003 and chaired by Nevin Murray. There were a total of 3344 registrants from 77 countries and 1149 abstracts were submitted. Awards presented by IASLC president Harubumi Kato included: the IASLC Merit Award to Paul A. Bunn, Mary Matthews Pathology Award to Adi Gazdar, BMS IASLC Distinguished Achievement Award to Paul van Houtte and The IASLC Distinguished Service Award to Heine H. Hansen. The closing gala dinner hosted 2500 delegates with entertainment by “Cirque Pacifique”. The Vancouver meeting maintained the tradition that IASLC conferences grow in size and academic content without compromise of an atmosphere of international collegiality.
The new International Convention Center of Barcelona, located in the heart of a new activity area of Barcelona on the shores of the Mediterranean, was the venue for the 11th World Conference on Lung Cancer, chaired by Rafael Rosell and Laureano Molins. This was the largest World Conference yet, with a total of 4987 registrants from 92 countries and 1488 submitted abstracts. For the first time, a special Fellows' Day was scheduled in conjunction with the conference, encompassing topics that were appealing and useful to younger investigators. The main program of the conference included 87 sessions, with lectures given by 175 invited speakers and almost 500 contributors to the scientific program. IASLC awards included: the IASLC Merit Award to Harubumi Kato; the Mary Matthews Award to Elisabeth Brambilla; the IASLC Joseph Cullen Award to Nigel Gray; and the IASLC Scientific Award to Thierry LeChevalier. Ten Young Investigator Awards and ten Developing Nation Awards were also presented to outstanding delegates. The conference was a unique occasion for investigators from several disciplines to share their views on lung cancer research and join forces to create a useful approach to lung cancer management.
12th World Conference on Lung Cancer. The 12th IASLC World Conference took place at the COEX Convention Center in Seoul, Korea on September 2-6, 2007. The conference theme was “Let's Make Lung Cancer History”. The conference's main objectives were to:
* Provide a forum for a world free of tobacco-related cancer
* Provide a multidisciplinary forum to share the advancements in lung cancer prevention, diagnosis and treatment
* Disseminate scientific advances in lung cancer biology and pathogenesis into clinical practice
* Encourage new clinical trials based on recent progress in molecular studies of lung cancer
* Support the career development of fellows and junior faculty in lung cancer
The meeting had 4769 registered delegates plus 112 accompanying person registrations for a total of 4881 persons from 84 countries. A total of 1294 abstracts in eleven categories were submitted to the 12th World Conference of Lung Cancer from 68 countries.
Scientific highlights: The program included 4 plenary sessions (Tobacco or Health; Advances in Staging; Advances in Management of NSCLC; Presidential Symposium), 20 mini symposia, 24 Meet-the-Professor-Sessions, 21 Education Sessions, 2 Highlight of the Day Sessions and 15 Satellite Symposia. Four best abstracts were presented at the Presidential Symposium. Twenty-eight proffered paper sessions and six Poster Discussions were held and 210 oral papers and 144 poster discussion papers were presented. During three general Poster Display Sessions, 724 abstracts were shown.
IASLC Merit Award 2007 was given to Peter Goldstraw, MD, FRCS in recognition of his scientific and organisational leadership through many years. As a chair of the IASLC Staging Project since 1998, has lead to the collection of data over 100,000 cases treated by all modalities across the globe and it has guaranteed the IASLC a major role in formulating the 7th edition of the TNM classification for lung cancer. The Mary Matthews Award 2007 was given to Fred R. Hirsch, MD, PhD for his outstanding contributions to lung cancer research. Dr. Hirsch initiated the Pathology Committee within IASLC in 1983 and he has authored more than 200 scientific publications on lung cancer and is Editor of 10 international textbooks in oncology in general and on lung cancer in particular. Joseph Cullen Award 2007 was given to Dr. James L. Mulshine, MD. Dr. Mulshine has been working with a range of organizations to accelerate the use of high resolution spiral CT in the quantitative evaluation of drung response for early lung cancer over the last few years. IASLC Scientific Award 2007 was given to Dr. Frances Shepherd, MD, FRCPC. Dr. Shepherd has been instrumental in establishing Lung Cancer Tumor Banks in order to perform correlative science studies pertaining to lung cancer. Through her leadership, she has brought together a team of basic and clinical researchers committed to the evaluation of molecular pathways in lung cancer. This team is recognized world-wide as one of the foremost groups of bench to beside research pertaining to lung cancer. And Young Investigators Awards and Developing Nations Awards are given to ten junior scientists for each. Dan Idhe Lectureship, Bob Ginsberg Lectureship and Heine Hansen Lectureship is given to three abstracts.
Social Events: The opening Ceremony combined welcoming addresses from Prime Minister of Korea and IASLC president with Korean drumming and other traditional musical performances. The closing gala dinner was held at COEX Convention Hall. Hanbok (the Korean traditional costume) Fashion show and musical entertainment, Ballroom Dance were featured and attracted attention from international delegates. It was the time for all the delegates to relax and enjoy a fusion of Korean and Western foods and entertainment. Over the 3,000 registrants enjoyed.
One of the worthwhile achievements of the 12th WCLC is the revision to the Tobacco Declaration. At the 12th WCLC, IASLC added an article of “In order to help achieve its goal of eliminating lung cancer, IASLC requests government to initiate legislative action for ultimate elimination of manufacture and sales of tobacco products.”
The 13th World Lung Cancer Conference will be held in San Francisco, July/August, 2009. Drs. David Gandara and David Jablons are the conference co-chairs.
The 14th World Lung Cancer conference will be held in Amsterdam, The Netherlands, July 2-7, 2011. Dr. Pieter Postmus is the Conference chairman. ICS (International Conference Service), Vancouver, Canada has been chosen to arrange the coming World Conference 2007, 2009, and 2011.
The new IASLC Journal “Journal of Thoracic Oncology” started January 1, 2006 and published 9 issues in 2006. It published 12 issues in 2007, 2008 and 2009. Dr. James Jett is the Editor of the JTO and has seen the JTO off to a very successful start.
In 2002 Workshops, Symposia and Educational meetings have been arranged in Belgium, Italy, Austria, India, Taiwan.
In 2003 Workshops, Symposia and Educational meetings have been arranged in Lithuania, China, Spain.
In 2004 IASLC arranged eight workshops, symposia and educational meetings in Portugal, US, Switzerland, Thailand, Brazil, Poland and Germany.
In 2005 IASLC arranged eight workshops, symposia and educational meetings in the UK, Japan, India, Indonesia, Russia, China, Turkey and US.
In 2006 the IASLC arranged 11 workshops in Ireland, US, Mexico, Czech Republic, Australia, Italy, China, Turkey and Italy.
In 2007 the IASLC arranged 5 workshops in Ireland, Italy, US, Turkey, Spain, Austria.
In 2008 the IASLC arranged 7 workshops in US, Thailand, Switzerland, UK, Australia, Germany.
In 2009 the IASLC arranged 10 workshops in Ireland, US, Belgium, France, India, Turkey, Brazil.
In 2008 two new initiatives began. In April: IASLC and ESMO jointly arranged 1st European Lung Cancer Conference in Geneva, Switzerland and in November 2009 the IASLC, ASTRO, ASCO and University of Chicago arranged the 2008 Multidisciplinary Symposium in Thoracic Oncology in Chicago. Seven workshops in US, Thailand, Switzerland, UK, Chile and India were sponsored by the IASLC. The Latin American Lung Cancer Conference was held in Vina del Mar, Chile from October 9-10, 2008. Dr. N. Yamaguchi was the chair of the meeting. The Asia Pacific Lung Cancer Conference was held in Hyderabad, India from December 5-7, 2008. Dr. P. Parikh was the chair of the meeting. Seven workshops in US, France, Brazil, India, UK and Turkey are planned to be sponsored by IASLC in 2009.
The 15th World Conference on Lung Cancer will be held in Sydney, Australia on October 27-November 1, 2013. Dr. Kwun Fong is the Conference Chairman.
The 16th World Conference on Lung Cancer will be held in Denver, Colorado, US in September 2010. Dr. Fred R. Hirsch is the Conference Chairman.
The JTO is listed in pubmed Spring 2007 and will receive its first impact factor in 2009. Manuscript submission increased from 300 in 2006 to 600 in 2008. Manuscript submissions have gone from 310 in 2006 to 779 in 2009. In 2009 we received our first full impact factor of 3.5 which is considered excellent for a new journal.”
The first-ever site-specific guides on the updated TNM classification of thoracic malignancies were published in 2009 by the IASLC with support from Editorial Rx Press. The Staging Manual (print and CD) and Handbook in Thoracic Oncology, Peter Goldstraw, FRCS, Executive Editor, were produced in association with the UICC and AJCC and coordinated with publication of the 7th editions of the TNM Classification of Malignant Tumors/UICC and AJCC Cancer Staging Manual. The IASLC publications include IASLC-original illustrations (IASLC Nodal Chart, Visceral Pleural Invasion, and TNM Atlas of Illustrations). In addition to the Manual and Handbook, the new thoracic oncology staging information is also available in reference card and poster formats. IASLC members received special discounted pricing for these publications and products.
A 35-year history of the IASLC was also published in 2009, with Heine Hansen, MD, Editor. Following its announcement at the 2009 WCLC, IASLC members received a complimentary copy.
SUMMARY OF THE 13TH WORLD CONFERENCE ON LUNG CANCER
The 13th IASLC World Conference, held at the Moscone West Convention Center in San Francisco and co-chaired by Drs. David Jablons and David Gandara, can be considered a great success by any measure: the largest attendance ever at this event (6,215 attendees), the broadest representation from different counties (delegates from 85 different countries), the largest number of submitted abstracts (1531), over 300 speakers and the largest number of satellite symposia (13) ever at a World Conference. Record attendance at the Young Investigators Symposium exceeded all expectations, with 420 attendees from around the world.
Scientific Highlights: The Opening Ceremony was highlighted by an address from John Niederhuber, Director of the US National Cancer Institute. The Scientific Program featured an expanded number of simultaneous sessions, designed to facilitate wide participation and interaction among attendees. The Program included 3 plenary sessions (Personalized Therapy, State of the Art and Implementation of IASLC Revised Staging System) and a Presidential Symposium featuring 4 of the best submitted abstracts, covering the breadth of basic and clinic research represented within IASLC membership.
IASLC Merit Award is given to a member of IASLC, who has made an extraordinary contribution to the organization's development (Dr. Giorgio Scagliotti). IASLC Scientific Award is given to an IASLC scientist for life-time scientific contribution in thoracic malignancy research and who has also contributed to the organization's development Dr. Bruce Johnson and Dr. Thomas Lynch). Mary J. Matthews Award is given to an IASLC scientist for life-time scientific achievements in pathology-translational research of thoracic malignancies (Dr. Masayuki Noguchi). Joseph W. Cullen Award is given to an IASLC scientist for life-time scientific achievements in prevention research of thoracic malignancies (Dr. Stephen Lam).
Attendees to the 13th World Conference on Lung Cancer were treated to an exciting Social Program, including an Opening Ceremony, Welcome Reception and optional Gala Dinner. Both the Opening Ceremony and Welcome Reception were inclusive with Full registration. Tickets for the Gala Dinner, featuring a performance by The Beach Boys, for registered attendees and registered accompanying guests.
The conference also held a President's Reception and Faculty Dinner by invitation only. A complimentary Social Excursion was offered during the 13th World Conference on Lung Cancer which provided delegates a chance to discover the beauty of San Francisco's natural setting, fabulous foods, world-class venues and diverse cultural heritage. Complimentary Social Excursions took place. Delegates were provided with four (4) tour options in which they could participate. The social aspect is an integral part of the IASLC World Conference. Attendees, exhibitors and speakers enjoyed the opportunity to catch up with their peers, make new contacts and network throughout the program.